Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia

Translational Research

Volumn 158, Issue 4, 2011, Pages 225-234

  Glueck, Charles J ^a   Goldenberg, Naila ^a   Budhani, Shaaista ^a   Lotner, Daniel ^a   Abuchaibe, Cesar ^a   Gowda, Madan ^a   Nayar, Tushar ^a   Khan, Naseer ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CYANOCOBALAMIN; ENOXAPARIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; TESTOSTERONE; TESTOSTERONE ENANTATE; WARFARIN;

ADULT; AGED; ANDROGEN DEFICIENCY; BONE NECROSIS; CLINICAL ARTICLE; DRUG DOSE TITRATION; DRUG MEGADOSE; FAMILIAL DISEASE; HETEROZYGOSITY; HIP OSTEONECROSIS; HIP OSTEONEROSIS; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; REVIEW; THROMBOPHILIA; THROMBOSIS; TRANSITIONAL BLINDNESS;

EID: 80053001335     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.06.003     Document Type: Review

References (66)

1. C.J. Glueck, R. Freiberg, T. Tracy, D. Stroop, and P. Wang Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis Clin Orthop Relat Res 334 1997 43 56 (Pubitemid 27034874)
2. C.J. Glueck, R.A. Freiberg, L. Sieve, and P. Wang Enoxaparin prevents progression of stages I and II osteonecrosis of the hip Clin Orthop Relat Res 435 2005 164 170 (Pubitemid 40798658)
3. L.C. Jones, M.A. Mont, and T.B. Le Procoagulants and osteonecrosis J Rheumatol 30 2003 783 791 (Pubitemid 36402774)
4. C.G. Zalavras, G. Vartholomatos, E. Dokou, K.N. Malizos, and V. Factor Leiden and prothrombin gene mutations in femoral head osteonecrosis Thromb Haemost 87 2002 1079 1080 (Pubitemid 34624896)
5. A. Bjorkman, I.M. Burtscher, and P.J. Svensson Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee Arch Orthop Trauma Surg 125 2005 51 55 (Pubitemid 40305469)
6. A. Bjorkman, P.J. Svensson, and A. Hillarp Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults Clin Orthop Relat Res 425 2004 168 172 (Pubitemid 39062765)
7. V.V. Balasa, R.A. Gruppo, and C.J. Glueck Legg-Calve-Perthes disease and thrombophilia J Bone Joint Surg Am 86A 2004 2642 2647
8. J.D. Chang, M. Hur, S.S. Lee, J.H. Yoo, and K.M. Lee Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population Clin Orthop Relat Res 466 2008 1041 1046
9. C.J. Glueck, R.E. McMahon, and J.E. Bouquot Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens J Lab Clin Med 130 1997 540 543 (Pubitemid 27526337)
10. C.J. Glueck, R.N. Fontaine, and R. Gruppo The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis Clin Orthop Relat Res 366 1999 133 146 (Pubitemid 29439347)
11. C.J. Glueck, R.A. Freiberg, R.N. Fontaine, T. Tracy, and P. Wang Hypofibrinolysis, thrombophilia, osteonecrosis Clin Orthop Relat Res 386 2001 19 33 (Pubitemid 32391273)
12. C.J. Glueck, R.A. Freiberg, and P. Wang Heritable thrombophilia- hypofibrinolysis and osteonecrosis of the femoral head Clin Orthop Relat Res 466 2008 1034 1040
13. C.J. Glueck, K. Golnik, and W. Ping Amaurosis fugax caused by heritable thrombophilia-hypofibrinolysis in cases without carotid atherosclerosis: thromboprophylaxis prevents subsequent transient monocular partial blindness Clin Appl Thromb Hemost 13 2007 124 129 (Pubitemid 46548363)
14. F. Cacciapuoti Some considerations about the hypercoagulable states and their treatments Blood Coagul Fibrinolysis 22 2011 155 159
15. O. Yokus, M. Albayrak, and O.S. Balcik Risk factors for thrombophilia in young adults presenting with thrombosis Int J Hematol 90 2009 583 590
16. M.T. DeSancho, N. Berlus, P.J. Christos, and J. Rand Risk factors for clinical manifestations in carriers of factor V Leiden and prothrombin gene mutations Blood Coagul Fibrinolysis 21 2010 11 15
17. M.M. Cherrier, A.M. Matsumoto, and J.K. Amory The role of aromatization in testosterone supplementation: effects on cognition in older men Neurology 64 2005 290 296
18. E.A. Jankowska, P. Rozentryt, and B. Ponikowska Circulating estradiol and mortality in men with systolic chronic heart failure JAMA 301 2009 1892 1901
19. D.I. Spratt, J.R. Morton, and R.S. Kramer Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization Am J Physiol Endocrinol Metab 291 2006 E631 E638
20. A. Vermeulen, J.M. Kaufman, S. Goemaere, and I. van Pottelberg Estradiol in elderly men Aging Male 5 2002 98 102
21. R.S. Swerdloff, C. Wang, and G. Cunningham Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men J Clin Endocrinol Metab 85 2000 4500 4510 (Pubitemid 32157624)
22. C. Wang, G. Cunningham, and A. Dobs Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men J Clin Endocrinol Metab 89 2004 2085 2098 (Pubitemid 38619836)
23. R.D. Abbott, L.J. Launer, and B.L. Rodriguez Serum estradiol and risk of stroke in elderly men Neurology 68 2007 563 568
24. J.L. Ockrim, N. Lalani el, A.K. Kakkar, and P.D. Abel Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism J Urol 174 2005 527 533 discussion 32-3
25. B. von Schoultz, K. Carlstrom, and L. Collste Estrogen therapy and liver function - metabolic effects of oral and parenteral administration Prostate 14 1989 389 395 (Pubitemid 19208212)
26. P.O. Hedlund, H. Gustafson, and S. Sjogren Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients Scand J Urol Nephrol Suppl 55 1980 103 105
27. A.W. Toorians, M.C. Thomassen, and S. Zweegman Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people J Clin Endocrinol Metab 88 2003 5723 5729 (Pubitemid 38033041)
28. K.W. Bloemenkamp, F.R. Rosendaal, F.M. Helmerhorst, H.R. Buller, and J.P. Vandenbroucke Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen Lancet 346 1995 1593 1596 (Pubitemid 26001841)
29. E. Hoibraaten, M.C. Mowinckel, H. de Ronde, R.M. Bertina, and P.M. Sandset Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial Br J Haematol 115 2001 415 420 (Pubitemid 34203511)
30. C. Kluft Effects of hormone treatment on hemostasis variables Climacteric 10 Suppl. 2 2007 32 37 (Pubitemid 47450852)
31. E. Oger, M. Alhenc-Gelas, and K. Lacut Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler Thromb Vasc Biol 23 2003 1671 1676 (Pubitemid 37108215)
32. I.C. Weitz, V.K. Israel, and H.A. Liebman Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden Cancer 79 1997 2024 2027 (Pubitemid 27200388)
33. J.E. Garber, S. Halabi, and S.M. Tolaney Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer J Natl Cancer Inst 102 2010 942 949
34. J.L. Lycette, S.W. Luoh, T.M. Beer, and T.G. Deloughery Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: case report and review of the literature Breast Cancer Res Treat 99 2006 249 255 (Pubitemid 44337916)
35. B.J. Montella, J.A. Nunley, and J.R. Urbaniak Osteonecrosis of the femoral head associated with pregnancy. A preliminary report J Bone Joint Surg Am 81 1999 790 798 (Pubitemid 29297557)
36. O.F. Ugwonali, H. Sarkissian, and O.A. Nercessian Bilateral osteonecrosis of the femoral head associated with pregnancy: four new cases and a review of the literature Orthopedics 31 2008 183
37. V.V. Balasa, R.A. Gruppo, and C.J. Glueck The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults Thromb Haemost 81 1999 739 744 (Pubitemid 29216560)
38. C.J. Glueck, R.N. Fontaine, and P. Wang Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke Thromb Haemost 85 2001 256 259 (Pubitemid 32140569)
39. C.J. Glueck, P. Wang, H. Bell, V. Rangaraj, and N. Goldenberg Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation J Lab Clin Med 143 2004 184 192 (Pubitemid 38352540)
40. C.J. Glueck, P. Wang, N. Goldenberg, and L. Sieve Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin Clin Appl Thromb Hemost 10 2004 323 334 (Pubitemid 39391292)
41. C.J. Glueck, N. Goldenberg, H. Bell, K. Golnik, and P. Wang Amaurosis fugax: associations with heritable thrombophilia Clin Appl Thromb Hemost 11 2005 235 241 (Pubitemid 41022852)
42. C.J. Glueck, P. Wang, H. Bell, V. Rangaraj, and N. Goldenberg Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion Clin Appl Thromb Hemost 11 2005 375 389 (Pubitemid 41546764)
43. C.J. Glueck, J. Pranikoff, and D. Aregawi The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage Metabolism 54 2005 1345 1349 (Pubitemid 41262592)
44. C.J. Glueck, D. Aregawi, and N. Goldenberg Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia J Lab Clin Med 145 2005 72 82 (Pubitemid 40298732)
45. C.J. Glueck, H.I. Glueck, T. Tracy, J. Speirs, C. McCray, and D. Stroop Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer Metabolism 42 1993 236 246 (Pubitemid 23051468)
46. Roche Diagnostics GmbH. Testosterone II, Estradiol II: electrochemiluminescence immunoassay, Reference #s 05200067 160, 03000079 122. 2010:1-5.
47. LabCorp Testosterone, Free, Serum (Equilibrium Ultrafiltration) LabCorp Manual 2011 1 3
48. I. Vlahos, W. MacMahon, and D. Sgoutas An improved ultrafiltration method for determining free testosterone in serum Clin Chem 28 1982 2286 2291 (Pubitemid 13234574)
49. R.P. Ficat Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment J Bone Joint Surg Br 67 1985 3 9 (Pubitemid 15037534)
50. C.J. Glueck, R.A. Freiberg, S. Boppana, and P. Wang Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis J Bone Joint Surg Am 90 2008 2220 2229
51. S. Basaria, A.D. Coviello, and T.G. Travison Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
52. M.M. Fernandez-Balsells, M.H. Murad, and M. Lane Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 2010 2560 2575
53. K.M. Lakshman, B. Kaplan, and T.G. Travison The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men J Clin Endocrinol Metab 95 2010 3955 3964
54. P.A. Kyrle, E. Minar, and M. Hirschl High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 2000 457 462 (Pubitemid 30646484)
55. P.A. Kyrle, and S. Eichinger The risk of recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism Wien Klin Wochenschr 115 2003 471 474 (Pubitemid 37047475)
56. N. Kokturk, A. Kanbay, and M. Aydogdu Hyperhomocysteinemia prevalence among patients with venous thromboembolism Clin Appl Thromb Hemost 2010 Aug 10 [Epub ahead of print]
57. C. Wang, D.H. Catlin, L.M. Demers, B. Starcevic, and R.S. Swerdloff Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J Clin Endocrinol Metab 89 2004 534 543 (Pubitemid 38269854)
58. P.M. Ridker, J.P. Miletich, C.H. Hennekens, and J.E. Buring Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening JAMA 277 1997 1305 1307 (Pubitemid 27194355)
59. D.S. Dizon-Townson, L.M. Nelson, H. Jang, M.W. Varner, and K. Ward The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis Am J Obstet Gynecol 176 1997 883 886 (Pubitemid 27202950)
60. J.P. Gregg, A.J. Yamane, and W.W. Grody Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations Am J Med Genet 73 1997 334 336 (Pubitemid 27509913)
61. P.G. Lindqvist, and B. Dahlback Carriership of factor V Leiden and evolutionary selection advantage Curr Med Chem 15 2008 1541 1544 (Pubitemid 351997785)
62. P.H. Reitsma Genetic heterogeneity in hereditary thrombophilia Haemostasis 30 Suppl 2 2000 1 10 (Pubitemid 32234133)
63. S. Liljeqvist, A. Hellden, U. Bergman, and M. Soderberg Pulmonary embolism associated with the use of anabolic steroids Eur J Intern Med 19 2008 214 215 (Pubitemid 351459624)
64. F.O. Erkekol, A. Ulu, N. Numanoglu, and N. Akar High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism Respirology 11 2006 70 74
65. C.L. Wong, R. Szydlo, S. Gibbs, and M. Laffan Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension Blood Coagul Fibrinolysis 21 2010 201 206
66. C.J. Glueck, W. Ping, R. Hutchins, M.R. Petersen, and K. Golnik Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions Clin Appl Thromb Hemost 14 2008 286 294 (Pubitemid 351871938)